Antihistamine use may improve oncologic and survival outcomes in patients receiving second-line atezolizumab for advanced or metastatic urothelial carcinoma, according to research published in ...
Sign In We don’t recognize that sign in. Your username maybe be your email address. Passwords are 6-20 characters with at least one number and letter. We still don’t recognize that sign in.